Search Results - "Bazhenova, L."

Exploring the role of accessory biomarkers TMB, STK11, KEAP1, and KRAS in non-small-cell lung cancer: confused, but on a much higher level by Bazhenova, L.

Get full text

Corrigendum to “Exploring the role of accessory biomarkers TMB, STK11, KEAP1, and KRAS in non-small-cell lung cancer: confused, but on a much higher level”: [Annals of Oncology 34 (2023) 327-332] by Bazhenova, L.

Get full text

CNS response to osimertinib in patients with T790M-positive advanced NSCLC: pooled data from two phase II trials by Goss, G., Tsai, C.-M., Shepherd, F.A., Ahn, M.-J., Bazhenova, L., Crinò, L., de Marinis, F., Felip, E., Morabito, A., Hodge, R., Cantarini, M., Johnson, M., Mitsudomi, T., Jänne, P.A., Yang, J.C.-H.

“…Central nervous system (CNS) metastases are common in patients with non-small-cell lung cancer (NSCLC). Osimertinib has shown systemic efficacy in patients…”
Get full text

A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer by Giaccone, G, Bazhenova, L.A, Nemunaitis, J, Tan, M, Juhász, E, Ramlau, R, van den Heuvel, M.M, Lal, R, Kloecker, G.H, Eaton, K.D, Chu, Q, Dunlop, D.J, Jain, M, Garon, E.B, Davis, C.S, Carrier, E, Moses, S.C, Shawler, D.L, Fakhrai, H

“…Abstract Background Treatment options after first-line chemotherapy are limited in non-small cell lung cancer (NSCLC). Belagenpumatucel-L is a therapeutic…”
Get full text

Noise Sources of Aerodynamic Origin in Air Blowers by Bazhenova, L. A.

“…The paper presents the results of theoretical and experimental studies of the occurrence and locations of aerodynamic noise sources in air blowers related to…”
Get full text

KRYSTAL-1: Activity and Safety of Adagrasib (MRTX849) in Advanced/ Metastatic Non–Small-Cell Lung Cancer (NSCLC) Harboring KRAS G12C Mutation by Jänne, P.A., Rybkin, I.I., Spira, A.I., Riely, G.J., Papadopoulos, K.P., Sabari, J.K., Johnson, M.L., Heist, R.S., Bazhenova, L., Barve, M., Pacheco, J.M., Leal, T.A., Velastegui, K., Cornelius, C., Olson, P., Christensen, J.G., Kheoh, T., Chao, R.C., Ou, S.H.I.

Get full text

Efficacy and safety of entrectinib in patients with NTRK fusion-positive (NTRK-fp) Tumors: Pooled analysis of STARTRK-2, STARTRK-1 and ALKA-372-001 by Demetri, G.D., Paz-Ares, L., Farago, A.F., Liu, S.V., Chawla, S.P., Tosi, D., Kim, E.S., Blakely, C., Krauss, J.C., Sigal, D., Bazhenova, L., John, T., Besse, B., Wolf, J., Seto, T., Chow-Maneval, E., Multani, P.S., Johnson, A.D., Simmons, B., Doebele, R.C.

Get full text

Entrectinib in NTRK fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of patients (pts) enrolled in STARTRK-2, STARTRK-1 and ALKA-372-001 by Paz-Ares, L., Doebele, R.C., Farago, A.F., Liu, S.V., Chawla, S.P., Tosi, D., Blakely, C.M., Krauss, J.C., Sigal, D., Bazhenova, L., John, T., Besse, B., Wolf, J., Seto, T., Chow-Maneval, E., Ye, C., Simmons, B., Demetri, G.D.

Get full text

Sitravatinib demonstrates activity in patients with novel genetic alterations that inactivate CBL by Bazhenova, L, Carvajal, R D, Cho, B C, Eaton, K, Goel, S, Heist, R S, Ingham, M, Wang, D, Werner, T, Neuteboom, S, Potvin, D, Chen, I, Christensen, J, Chao, R, Alva, A

Get full text

Efficacy and safety of entrectinib in patients with NTRK fusion-positive tumours: Pooled analysis of STARTRK-2, STARTRK-1, and ALKA-372-001 by Demetri, G.D., Paz-Ares, L., Farago, A.F., Liu, S.V., Chawla, S.P., Tosi, D., Kim, E.S., Blakely, C.M., Krauss, J.C., Sigal, D., Bazhenova, L., John, T., Besse, B., Wolf, J., Seto, T., Chow-Maneval, E., Multani, P.S., Johnson, A., Simmons, B., Doebele, R.C.

Get full text

A randomized phase II trial of erlotinib or erlotinib and bevacizumab in patients with advanced EGFR mutant non-small cell lung cancer (NSCLC) by Stinchcombe, T.E., Janne, P.A., Wang, X., Bertino, E.M., Weiss, J.M., Bazhenova, L., Gu, L., Lau, C.J., Paweletz, C.P., Jaslowski, A.J., Gerstner, G.J., Baggstrom, M.Q., Graziano, S.L., Bearden, J., Vokes, E.E.

Get full text

Phase 1 Study of Accelerated Hypofractionated Radiation Therapy With Concurrent Chemotherapy for Stage III Non-Small Cell Lung Cancer: CALGB 31102 (Alliance) by Urbanic, J.J, Wang, X, Bogart, J.A, Stinchcombe, T, Hodgson, L, Schild, S.E, Bazhenova, L, Salgia, R, Vokes, E.E

Get full text

Phase Ib/II trial of NC-6004 (nanoparticle cisplatin) plus gemcitabine (G) in patients (pts) with advanced solid tumors by Subbiah, V, Combest, A, Grilley-Olson, J, Sharma, N, Andrews, E, Bobe, I, Balkissoon, J, Camp, A, Masada, A, Reitsma, D, Bazhenova, L

“…Background: NC-6004 is a polymeric micelle exhibiting sustained release of cisplatin (CDDP) and selective distribution to tumors due to the enhanced…”
Get full text

Effect of external actions on the characteristics of vortex sound by Bazhenova, L. A.

“…The dependence of the characteristics of vortex sound caused by an air flow around a rigid cylinder on various factors, including the turbulence of the…”
Get full text

A phase 1/1b study of RXDX-105, an oral RET and BRAF inhibitor, in patients with advanced solid tumors by Drilon, A, Marwan, F, Fu, S, Patel, M.R, Olszanski, A.J, Lockhart, A.C, Liu, S.V, Bazhenova, L, Seery, T, Nikolinakos, P, Patel, R, Oliver, J.W, Multani, P.S, Wang, D

“…Background: RXDX-105 is a multikinase inhibitor that has demonstrated potent inhibition of RET and BRAF with biochemical IC50 values of 0.3-0.8 nM against RET…”
Get full text

3113 AZD9291 in pre-treated patients with T790M positive advanced non-small cell lung cancer (NSCLC): Pooled analysis from two Phase II studies by Goss, G.D, Yang, J.C.H, Ahn, M.J, Tsai, C.M, Bazhenova, L, Sequist, L.V, Ramalingam, S.S, Shepherd, F.A, Ghiorghiu, S, Cantarini, M, Mann, H, Mitsudomi, T, Jänne, P.A

Get full text

3083 AZD9291 activity in patients with EGFR-mutant advanced non-small cell lung cancer (NSCLC) and brain metastases: Data from Phase II studies by Ahn, M.J, Tsai, C.M, Yang, J.C.H, Shepherd, F.A, Satouchi, M, Kim, D.W, Bazhenova, L, Hirashima, T, Rukazenkov, Y, Cantarini, M, Mann, H, Ramalingam, S.S, Mitsudomi, T, Jänne, P.A, Goss, G.D

Get full text

On the influence of the Reynolds number on the intensity of vortex sound flowing around a cylindrical profile by Bazhenova, L. A., Semenov, A. G.

“…Regularities of the emission of vortex sound (eolian tone) during air flow around stationary and rotating cylindrical profiles have been investigated. The…”
Get full text

Stereotactic Body Radiation Therapy in Octogenarians With Early-Stage Lung Cancer by Lau, S, Rahn, D, Nath, S.K, Kim, D, Song, W.Y, Gulaya, S, Fuster, M.M, Bazhenova, L, Mundt, A.J, Sandhu, A.P

Get full text

81: Efficacy and safety of AP26113 in ALK+ non-small cell lung cancer (NSCLC), including patients with brain metastases by Gettinger, S.N, Bazhenova, L, Salgia, R, Langer, C.J, Gold, K.A, Rosell, R, Shaw, A.T, Weiss, G.J, Narasimhan, N.I, Dorer, D.J, Rivera, V.M, Clackson, T, Haluska, F.G, Camidge, D.R

Get full text